Picture [MSC] – The Mass Spectrometry Web Portal 600x80px

News > All

Total search results: 9063 | Ordered by Date (descending)
1 2 3 ... 89 90 91  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Bayer AG. (3/20/18). "Press Release: Bayer and Ginkgo Bioworks Unveil Joint Venture, Joyn Bio, and Establish Operations in Boston and West Sacramento". Leverkusen & Boston, MA. 2018-03-20
Oxford Nanopore Technologies Ltd.. (3/20/18). "Press Release: Oxford Nanopore Announces £100 Million ($140M) Fundraising from Global Investors". Oxford. 2018-03-20
EBD Group. (3/20/18). "Press Release: Amsterdam Welcomed 2,500 Life Science Executives for Productive Partnering Last Week at BIO-Europe Spring 2018". Carlsbad, CA & Amsterdam. 2018-03-20
BRAIN AG. (3/17/18). "Press Release: BRAIN AG Acquires Majority Stake of Leading Speciality Enzyme Producer Biocatalysts Ltd.". Zwingenberg & Cardiff. 2018-03-17
H. Lundbeck A/S. (3/16/18). "Press Release: Lundbeck to Acquire Prexton Therapeutics Adding Foliglurax in Clinical Phase II to Its Pipeline of Innovative Treatments for Patients Suffering from Parkinson's Disease". Valby & Oss. 2018-03-16
Argen-X N.V. (Argenx). (3/16/18). "Press Release: Argenx Awarded €2.5 Million VLAIO Grant to Identify Novel Therapeutic Antibodies". Breda & Ghent. 2018-03-16
Siemens AG. (3/16/18). "Press Release: Siemens Healthineers AG Successfully Debuts on the Frankfurt Stock Exchange [Not for United States, Australia, Canada or Japan]". Erlangen. 2018-03-16
Thermo Fisher Scientific Inc.. (3/16/18). "Press Release: Thermo Fisher Scientific Announces Plans to Build State-of-the-Art Pharma Services Facility in Rheinfelden (Baden) Germany". Rheinfelden. 2018-03-16
Valbiotis S.A.. (3/15/18). "Press Release: Valbiotis Obtains Strategic Patent for Valedia in the United States". La Rochelle. 2018-03-15
Ardena. (3/15/18). "Press Release: Ardena Acquires ChemConnection Adding API Expertise". 2018-03-15
Thermo Fisher Scientific Inc.. (3/15/18). "Press Release: Charité – Universitätsmedizin Berlin Joins Thermo Fisher Scientific’s Next-Generation Sequencing Center of Excellence Program". Berlin & Carlsbad, CA. 2018-03-15
Bruker Corporation. (3/14/18). "Press Release: Bruker Appoints Gerald Herman as Interim Chief Financial Officer". Billerica, MA. 2018-03-14
Arsanis, Inc.. (3/14/18). "Press Release: Arsanis Granted Key Patents for ASN100 Covering Cross-neutralizing S. aureus Toxin Antibodies". Waltham, MA & Vienna. 2018-03-14
PixCell Medical Technologies. (3/14/18). "Press Release: PixCell Medical Awarded 2.5 Million Euros Grant by the European Commission to Support Commercialization of its Disruptive Blood Testing Technology". Yokneam. 2018-03-14
Forbion Capital Partners. (3/13/18). "Press Release: Forbion Leads $19 Million Series B Financing of Escalier Biosciences to Advance Its Topical and Systemic RORgammat Therapies for Psoriasis and other Autoimmune Diseases". 2018-03-13
Escalier Biosciences B.V.. (3/13/18). "Press Release: Escalier Biosciences Raises $19 Million to Develop Its Topical and Systemic RORyt Therapies for Psoriasis and other Autoimmune Diseases". Nijmegen. 2018-03-13
Bruker Corporation. (3/12/18). "Press Release: Bruker and Evosep Announce New Integrated Clinical Research Proteomics Solution to Quantify Over a Thousand Proteins in Five Minutes". Minneapolis, MN. 2018-03-12
bio.logis Genetic Information Management GmbH. (3/12/18). "Press Release: Personalized Medicine. Medical University of Vienna (MUW) to Collaborate with bio.logis GIM in Pharmacogenetics". 2018-03-12
Novartis AG. (3/12/18). "Press Release: Novartis Announces Changes to the Executive Committee to Support Strategic Priorities". Basel. 2018-03-12
Domainex Ltd.. (3/12/18). "Press Release: Domainex Appoints Dr Bodo Spori as Head of Business Development for Europe". Cambridge. 2018-03-12
Pieris Pharmaceuticals, Inc.. (3/9/18). "Press Release: Pieris Pharmaceuticals Reports Full-Year 2017 Financial Results and Corporate Update". Boston, MA. 2018-03-09
Rentschler Biopharma SE. (3/9/18). "Press Release: Rentschler Biopharma and Leukocare Demonstrate Success of Strategic Alliance for Biopharmaceutical Development and Formulation". Laupheim & Martinsried. 2018-03-09
Arsanis, Inc.. (3/9/18). "Press Release: Arsanis Reports Financial Results and Highlights for Fourth Quarter and Full Year 2017". Waltham, MA & Vienna. 2018-03-09
Sanofi S.A.. (3/8/18). "Press Release: Sanofi Completes Acquisition of Bioverativ Inc.". Paris. 2018-03-08
Evotec AG. (3/8/18). "Press Release: Evotec and Sanofi in Exclusive Talks to Create an Evotec-led Infectious Disease Open Innovation R&D Platform". Hamburg & Paris. 2018-03-08
InflaRx N.V.. (3/8/18). "Press Release: InflaRx Announces First Patient Enrolled in Phase IIb Trial with Lead Candidate IFX-1 in Hidradenitis Suppurativa". Jena. 2018-03-08
ProBioGen AG. (3/8/18). "Press Release: ProBioGen and Surface Oncology Sign Second Antibody Manufacturing Program". Berlin. 2018-03-08
CRISPR Therapeutics AG. (3/8/18). "Press Release: CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2017 Financial Results". Zug & Cambridge, MA. 2018-03-08
Charles River Laboratories International, Inc.. (3/8/18). "Press Release: Charles River Laboratories Makes Expansions to Global Biologics Infrastructure". Wilmington, MA. 2018-03-08
Roche. (3/8/18). "Press Release: Changes to the Roche Enlarged Corporate Executive Committee". Basel. 2018-03-08
Selcia Ltd.. (3/8/18). "Press Release: Parkinson's UK, Selcia, and Cresset Collaborate to Discover New Drug Candidates for Parkinson's". London, Ongar & Cambridge. 2018-03-08
Agilent Technologies Inc.. (3/7/18). "Press Release: Agilent Technologies to Acquire Advanced Analytical Technologies, Inc.". Santa Clara, CA. 2018-03-07
Bone Therapeutics S.A.. (3/7/18). "Press Release: Bone Therapeutics Announces Private Placement of Convertible Bonds [Not for the United States, Australia, Canada, Japan, South Africa, et al.]". Gosselies. 2018-03-07
Bone Therapeutics S.A.. (3/7/18). "Press Release: Bone Therapeutics Successfully Raises EUR 19.45 Million of Commitments in Convertible Bond Placement [Not for the United States, Australia, Canada, Japan, South Africa, et al.]". Gosselies. 2018-03-07
Novartis AG. (3/7/18). "Press Release: Novartis Expands Alliance with Science 37 to Advance Virtual Clinical Trials Program". Basel. 2018-03-07
Merck KGaA. (3/7/18). "Press Release: Merck Announces Positive Phase IIB Results for Evobrutinib in Relapsing Multiple Sclerosis". Darmstadt. 2018-03-07
Curetis N.V.. (3/6/18). "Press Release: Curetis Subsidiary Ares Genetics Wins Incubator Stay in Silicon Valley". Amsterdam & San Diego, CA & Holzgerlingen. 2018-03-06
Novartis AG. (3/6/18). "Press Release: Novartis' Xolair Recommended in New Global Chronic Urticaria Guideline". Basel. 2018-03-06
Valbiotis S.A.. (3/6/18). "Press Release: LpD64 Acts on Alterations of the Microbiota Involved in the Development of Obesity". La Rochelle. 2018-03-06
Sanofi S.A.. (3/6/18). "Press Release: Sanofi’s Board of Directors Proposes Appointment of Emmanuel Babeau as New Independent Director". Paris. 2018-03-06
BRAIN AG. (3/6/18). "Press Release: BRAIN AG Establishes US Subsidiary to Strengthen Business Development in North America". Zwingenberg. 2018-03-06
BIA Separations d.o.o.. (3/5/18). "Press Release: BIA Separations and Nuvonis Technologies Partner to Support Vaccine and Gene Therapy Production". Ajdovšcina & Vienna. 2018-03-05
Euronext N.V.. (3/5/18). "Press Release: Acacia Pharma Lists on Euronext Brussels". Brussels. 2018-03-05
Heidelberg Pharma AG. (3/5/18). "Press Release: Heidelberg Pharma and Magenta Therapeutics Sign Exclusive MultiTarget Research Agreement for the Development of Antibody Drug Conjugates". Ladenburg & Cambridge, MA. 2018-03-05
Owlstone Medical Ltd.. (3/5/18). "Press Release: Owlstone Medical Raises $15 Million USD (£11 Million GBP) with Horizons Ventures and Aviva". Cambridge. 2018-03-05
G1 Therapeutics, Inc.. (3/5/18). "Press Release: G1 Therapeutics Announces Positive Trilaciclib Phase 2a Topline Data Showing Robust Myelopreservation Benefits in Patients with Small Cell Lung Cancer". Research Triangle Park, NC. 2018-03-05
Autolus Ltd.. (3/5/18). "Press Release: Autolus Announces Confidential Submission of Draft Registration Statement for Potential Initial Public Offering in the United States". London. 2018-03-05
Acacia Pharma Group Ltd.. (3/2/18). "Press Release: Acacia Pharma Successfully Prices Initial Global Offering at EUR 3.60 per Share Raising EUR40m [Not for US, AU, CA, JP, ZA, et al.]". Cambridge & Indianapolis, IN. 2018-03-02
Biogen Inc.. (3/2/18). "Press Release: Biogen and AbbVie Announce the Voluntary Worldwide Withdrawal of Marketing Authorizations for Zinbryta (daclizumab) for Relapsing Multiple Sclerosis". Cambridge, MA & North Chicago, IL. 2018-03-02
Business France. (3/2/18). "Press Release: Biotechnology and Laboratory Technology from France at Analytica". 2018-03-02
IME Technologies. (3/2/18). "Press Release: Judith Heikoop Appointed Managing Director at Biomedical Electro Spinning Company IME Technologies". Geldrop. 2018-03-02
Ablynx N.V.. (3/2/18). "Press Release: Ablynx Commences Dosing in Its Phase II Study of ALX-0171 in Hospitalised Japanese Infants with a RSV Infection". Ghent. 2018-03-02
Finch Therapeutics Group, Inc.. (3/1/18). "Press Release: Finch Therapeutics Group Raises $36 Million in Series B Financing". Somerville, MA. 2018-03-01
Heidelberg Pharma AG. (3/1/18). "Press Release: Heidelberg Pharma Signs License Agreement with The University of Texas MD Anderson Cancer Center". Ladenburg. 2018-03-01
Affiris AG. (3/1/18). "Press Release: Affiris Announces Results of a Phase I Clinical Study Using Affitopes PD01A and PD03A, Confirming Safety and Tolerability for Both Compounds as well as Immunogenicity for PD01A in Early MSA patients". Vienna. 2018-03-01
Biocartis Group N.V.. (3/1/18). "Press Release: Biocartis Establishes R&D Center in the US". Mechelen. 2018-03-01
Biocartis Group N.V.. (3/1/18). "Press Release: European Union Provides Biocartis with up to EUR 24m Debt Financing Facility for Infectious Disease Projects". Mechelen. 2018-03-01
Oxford Immunotec Global plc. (3/1/18). "Press Release: Oxford Immunotec Announces Appointment of Mark Klausner to the Board of Directors". Oxford & Marlborough, MA. 2018-03-01
Biocartis Group N.V.. (3/1/18). "Press Release: Biocartis Announces 2017 Results and 2018 Outlook". Mechelen. 2018-03-01
Bruker Corporation. (3/1/18). "Press Release: Bruker Names Burkhard Prause, President of Bruker Energy & Supercon Technologies (BEST), an Executive Officer of Bruker Corporation". Billerica, MA. 2018-03-01
Rentschler Biopharma SE. (2/28/18). "Press Release: Rentschler Biopharma SE Appoints Federico Pollano as Senior Vice President, Business Development". Laupheim. 2018-02-28
Almac Group Ltd.. (2/28/18). "Press Release: Almac Group Expands with Opening of £20 Million Cold Chain Facility". Craigavon. 2018-02-28
bioMérieux S.A.. (2/28/18). "Press Release: 2017 Financial Results". 2018-02-28
BRAIN AG. (2/28/18). "Press Release: BRAIN AG Starts the Financial Year 2017/18 with a Weak First Quarter". Zwingenberg. 2018-02-28
Convert Pharmaceuticals S.A.. (2/28/18). "Press Release: Convert Pharmaceuticals Secures EUR 13.6 Million to Develop Anti-cancer Drugs". 2018-02-28
ERS Genomics Ltd.. (2/28/18). "Press Release: European Patent Office Grants Second Charpentier/Doudna Patent Covering CRISPR-Cas9 Gene Regulation Applications". Dublin. 2018-02-28
Agilent Technologies Inc.. (2/28/18). "Press Release: Agilent and Imperial College London Announce Collaboration Agreement". Santa Clara, CA. 2018-02-28
German Accelerator Life Sciences. (2/28/18). "Press Release: German Accelerator Life Sciences Appoints Vice President Germany". Berlin & Cambridge, MA. 2018-02-28
Grifols S.A.. (2/28/18). "Press Release: Grifols Revenues Exceed EUR 4,300 Million and Reported Profit Reaches EUR 663 Million". Barcelona. 2018-02-28
Novo Holdings A/S. (2/27/18). "Press Release: Novo Holdings Launches USD 165m Impact Fund to Combat Antimicrobial Resistance". Copenhagen. 2018-02-27
Basilea Pharmaceutica Ltd.. (2/27/18). "Press Release: Basilea Reports Significantly Improved Financial Results in 2017". Basel. 2018-02-27
BioPharmaSpec Ltd.. (2/27/18). "Press Release: BioPharmaSpec Launches New Host Cell Protein Detection Service". Malvern, PA & Jersey. 2018-02-27
Enyo Pharma S.A.. (2/27/18). "Press Release: Enyo Pharma Strengthens Its Leadership Team with a NASH Expert and Announces that Its Phase Ib Trial in Chronic HBV Infected Patients is on Track with Its FXR Agonist EYP001". Lyon. 2018-02-27
LifeArc. (2/27/18). "Press Release: LifeArc Announces £5M Support for Rare Disease Research". London. 2018-02-27
Hume Brophy. (2/27/18). "Press Release: Hume Brophy International Healthcare Launches New Life Sciences Division". London. 2018-02-27
Sotio a.s.. (2/27/18). "Press Release: Radek Špíšek to Become New CEO of Sotio". Prague. 2018-02-27
Synthelis. (2/27/18). "Press Release: Synthelis and BioMeca Sign a Commercial Agreement to Promote a Joint Service Offering". Lyon. 2018-02-27
Selexis S.A.. (2/26/18). "Press Release: Xencor Signs Four Commercial License Agreements with Selexis SA to Advance its Pipeline of XmAb Bispecific Antibody Drug Candidates". Geneva. 2018-02-26
Eurofins Scientific. (2/26/18). "Press Release: Eurofins Further Expands Its Specialty Clinical Diagnostics Footprint with the Acquisition of NMDL-LCPL in the Netherlands". 2018-02-26
Bavarian Nordic A/S. (2/26/18). "Press Release: Bavarian Nordic Announces Collaboration to Evaluate CV301 in Combination with Durvalumab in Colorectal and Pancreatic Cancers". Copenhagen. 2018-02-26
Valneva S.E.. (2/26/18). "Press Release: Emergent BioSolutions and Valneva Initiate Phase 1 Clinical Study to Evaluate Vaccine Candidate against Zika Virus". Gaithersburg, MD & Lyon. 2018-02-26
Bruker Corporation. (2/26/18). "Press Release: Bruker Highlights Innovative Analytical Solutions and Systems at Pittcon". Orlando, FL. 2018-02-26
Berlin Cures Holding AG. (2/26/18). "Press Release: Heart Failure Treatment from Berlin Cures Shows Promise in Phase 1 Study". Zug & Berlin. 2018-02-26
Catalyst Biosciences, Inc.. (2/26/18). "Press Release: Catalyst Biosciences Announces Manufacturing Agreement with AGC Biologics for Subcutaneous Factor IX Product CB 2679d". South San Francisco, CA. 2018-02-26
Eurofins Scientific. (2/23/18). "Press Release: Eurofins Becomes the Market Leader in Environment Testing Services in Ireland with the Acquisition of ELS and City Analysts". 2018-02-23
AstraZeneca plc. (2/23/18). "Press Release: Lynparza Receives Positive EU CHMP Opinion in Platinum-sensitive Relapsed Ovarian Cancer". 2018-02-23
AiCuris Anti-infective Cures GmbH. (2/23/18). "Press Release: AiCuris’ Licensee MSD Launches Prevymis (letermovir) in Germany". Wuppertal. 2018-02-23
ASIT Biotech S.A.. (2/23/18). "Press Release: ASIT Biotech Successfully Completes the Second Tranche of Its Capital Increase, Reaching a Total Amount Raised of €13.9 Million [Not for United States, Australia, Canada, Japan, et al.]". Brussels. 2018-02-23
Basilea Pharmaceutica Ltd.. (2/23/18). "Press Release: Basilea Reports Clinical Phase 3 Study Start with Antibiotic Ceftobiprole in Skin Infections under BARDA Contract". Basel. 2018-02-23
BCNP Consultants GmbH. (2/23/18). "Press Release: More than 1,200 Meetings at the 2nd European Chemistry Partnering". Frankfurt a. M.. 2018-02-23
Qiagen N.V.. (2/23/18). "Press Release: Qiagen Opens Shared Services Center in Taguig City, Manila". Manila. 2018-02-23
Streck, Inc.. (2/23/18). "Press Release: Streck, Inc. Files Suit against Cenata GmbH for Infringement of Its European Patent". La Vista, NE. 2018-02-23
BRAIN AG. (2/22/18). "Press Release: BRAIN AG Expands Patent Protection for Unique Taste Cell Technology to Europe". 2018-02-22
Bruker Corporation. (2/22/18). "Press Release: Bruker Acquires High-Speed QCL Infrared Microscopy Company IRM²". Ettlingen. 2018-02-22
Neovacs S.A.. (2/22/18). "Press Release: Neovacs Strengthens Its Intellectual Property in the USA". Paris & Boston, MA. 2018-02-22
Medigene AG. (2/21/18). "Press Release: Medigene Receives Approvals for Its First Clinical Trial with TCR Therapy MDG1011". Planegg. 2018-02-21
Basilea Pharmaceutica Ltd.. (2/21/18). "Press Release: Basilea's CEO Ronald Scott Will Retire. Chief Commercial Officer David Veitch Named as Successor – Changes in the Board of Directors". Basel. 2018-02-21
Arix Bioscience plc. (2/21/18). "Press Release: Arix Bioscience and Ipsen Sign a Strategic Agreement to Develop and Commercialise Innovative Therapies". London & Paris. 2018-02-21
Bruker Corporation. (2/21/18). "Press Release: Bruker Announces Resignation of Chief Financial Officer and Appointment of Principal Accounting Officer". Billerica, MA. 2018-02-21
G1 Therapeutics, Inc.. (2/21/18). "Press Release: G1 Therapeutics Reports Fourth Quarter and Full-Year 2017 Financial Results and Recent Operational Highlights". Research Triangle Park, NC. 2018-02-21
1 2 3 ... 89 90 91  next pagenext page


Picture Fairtec GmbH We Optimise the ROI of Your Event 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture Berlin Partner HealthCapital Bionnale 2018 Germany June 600x60px

» top


Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture Berlin Partner HealthCapital Bionnale 2018 Germany June 120x240px Picture [LSE] – The Business Web Portal 120x600px Picture Berlin Partner HealthCapital Bionnale 2018 June Matchmaking 120x240px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px